Thymosin Beta 4 Injection for Heart Attack Recovery
Part of Heart & circulation clinical trials.
This trial tests whether an injection of thymosin beta 4 (a natural protein) can help your heart recover after a specific type of heart attack (STEMI) when treated with emergency angioplasty. The goal is to reduce damage to heart muscle and improve heart function.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 75 years old
- You had a heart attack (STEMI) with a blocked artery in the front of your heart that needed emergency angioplasty
- Your heart attack symptoms started between 2 hours and 24 hours before treatment, depending on your heart's condition
- You have not had a prior heart attack, bypass surgery, or previous angioplasty
- You do not have severe heart failure, uncontrolled irregular heartbeats, or severe liver/kidney disease
- You must be able to undergo heart imaging (MRI) and agree to use contraception if of childbearing age
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new drug called ziltivekimab to see if it helps people who have recently had a heart attack. The drug is given as an injection and compared to a placebo (a shot with no active medicine).
This trial tests whether combining antioxidant supplements with standard heart attack care can reduce heart muscle damage. It may help people who are getting emergency treatment for their first heart attack.
This trial tests whether patients who have had a heart attack with a specific type of artery blockage can be safely treated without placing a metal stent (tube) in their artery. Doctors will monitor whether the blockage stays open on its own.
This study tests whether an injectable gel can protect your heart muscle after a heart attack when it's treated with emergency angioplasty. The gel is placed directly in the damaged area to reduce injury and improve heart function.
This trial tests a heart medication (a cardio-selective beta-blocker) given during a heart attack to see if it reduces damage to the heart muscle. It might help people having their first heart attack who are treated quickly with angioplasty (a procedure to open blocked arteries).
This trial tests whether giving specially prepared stem cells from your own blood can help your heart recover after a heart attack. You must have had a successful angioplasty or stenting within the last 4 weeks.
Hear when a new Acute Myocardial Infarction With ST Elevation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.